Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
13.89
-0.43 (-3.00%)
Oct 29, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Relyvrio (Sodium Phenylbutyrate and Taurursodiol)
87.37M
Log In
Log In
Log In
Log In
Upgrade
Relyvrio (Sodium Phenylbutyrate and Taurursodiol) Growth
-77.06%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
87.37M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-77.06%
Log In
Log In
Log In
Log In
Upgrade